<div id="readability-page-1"><p>Cinctive Capital Management LP purchased a new position in  HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 15,448 shares of the company's stock, valued at approximately $5,338,000.</p><ul><li>MarketBeat Week in Review – 07/28 - 08/01</li></ul><p>A number of other institutional investors also recently modified their holdings of HCA. Brighton Jones LLC acquired a new position in shares of  HCA Healthcare during the 4th quarter valued at $1,021,000.  Ameriprise Financial Inc. lifted its position in shares of  HCA Healthcare by 65.3% during the 4th quarter. Ameriprise Financial Inc. now owns 438,680 shares of the company's stock valued at $131,668,000 after acquiring an additional 173,330 shares during the period.  Baird Financial Group Inc. lifted its position in shares of  HCA Healthcare by 5.3% during the 4th quarter. Baird Financial Group Inc. now owns 29,278 shares of the company's stock valued at $8,788,000 after acquiring an additional 1,473 shares during the period.  Cary Street Partners Financial LLC bought a new stake in  HCA Healthcare during the 4th quarter valued at $187,000.  Finally, BOKF NA grew its stake in shares of  HCA Healthcare by 29.6% in the 4th quarter. BOKF NA now owns 5,401 shares of the company's stock worth $1,636,000 after acquiring an additional 1,232 shares in the last quarter. Institutional investors and hedge funds own  62.73% of the company's stock. </p><div><p><span></span><span>Get <strong>HCA Healthcare</strong> alerts:</span></p></div><h2>Analyst Upgrades and Downgrades</h2><p>A number of equities analysts recently weighed in on the stock. Wall Street Zen raised shares of HCA Healthcare from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, July 5th. Barclays lowered their target price on shares of HCA Healthcare from $416.00 to $390.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday, July 28th. Robert W. Baird increased their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, August 14th. Truist Financial increased their price objective on HCA Healthcare from $390.00 to $415.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, July 16th. Finally, JPMorgan Chase &amp; Co. raised their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a &#34;neutral&#34; rating in a research report on Monday, August 4th. One research analyst  has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $401.83.</p><ul><li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li></ul><p><b>Read Our Latest Research Report on HCA</b></p><h2>HCA Healthcare Stock Up 0.3%</h2><p>NYSE:HCA opened at $407.29 on Thursday. The firm's 50-day moving average price is $378.64 and its 200-day moving average price is $358.48. The company has a market capitalization of $95.30 billion, a PE ratio of 17.12, a P/E/G ratio of 1.27 and a beta of 1.41. The company has a debt-to-equity ratio of 69.07, a current ratio of 0.98 and a quick ratio of 0.86. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. </p><ul><li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li></ul><p>HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.50 EPS.  HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts predict that  HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year. </p><h2>HCA Healthcare Dividend Announcement</h2><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's payout ratio is presently 12.11%. </p><h2>About HCA Healthcare</h2> (Free Report)<p>HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than HCA Healthcare</li><li>Basic Materials Stocks Investing</li><li>With Rate Cuts Ahead, Buffett-Backed Builders Look Like a Buy</li><li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025 </li><li>Return of the ETFs: 3 Names That Could Keep Outperforming</li><li>Best ESG Stocks: 11 Best Stocks for ESG Investing</li><li>Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2><p>Before you consider HCA Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Cinctive Capital Management LP has invested $5.34 million in HCA Healthcare, acquiring 15,448 shares during the first quarter. Other institutional investors have also increased their stakes in HCA. Analysts have mixed ratings on the stock, with an average target price of $401.83. HCA Healthcare reported strong earnings, exceeding estimates, and declared a quarterly dividend of $0.72, payable on September 30th. The company has a market cap of $95.30 billion and a PE ratio of 17.12.</p>

Cinctive Capital Management LP Invests $5.34 Million in HCA Healthcare, Inc. $HCA